AI — Civic News India

3 weeks ago

AI Drug Rentosertib Enters Phase III for Lung Scarring

Insilico Medicine moves its AI-discovered drug rentosertib for idiopathic pulmonary fibrosis into Phase III trials, marking a key milestone for AI-driven drug discovery.

Civic News India

Read Story

Jul 06, 2026

UK Regulator Warns of AI Arms Race in Finance

UK regulator warns of an "arms race" to keep up with AI use in financial services, as millions use tools like ChatGPT for personal finance decisions.

Civic News India

Read

Jul 06, 2026

Station F F/ai Accelerator Boosts European AI Startups

Station F, the Paris startup hub, is launching a new edition of its F/ai accelerator to support Europe’s most promising AI startups with top investors.

Civic News India

Read

Jul 06, 2026

Microsoft Layoffs 2025: 4800 Jobs Cut in Xbox and Sales

Microsoft cuts around 4,800 jobs, or 2.1% of its workforce, hitting Xbox and commercial sales hardest. The layoffs raise fears about AI replacing jobs.

Civic News India

Read

Jul 06, 2026

New China AI Companion Rules Effective July 15

China’s new AI companion rules take effect July 15, targeting emotional bonds formed with chatbots. Beijing is cracking down on the risks of generative AI relationships.

Civic News India

Read

Jul 04, 2026

Mistral AI Guide: Open Source OpenAI Competitor

Mistral AI, a French startup backed by Nvidia, is a key OpenAI competitor. Learn about its open-source AI models, Le Chat assistant, and $6 billion valuation.

Civic News India

Read

Jul 03, 2026

Takeda Insilico AI Drug Discovery Deal $600M

Japanese pharma giant Takeda partners with Hong Kong-based Insilico Medicine in a US$600M AI drug discovery deal to accelerate early-stage research.

Civic News India

Read

Jul 02, 2026

Privacy Advocates Warn FTC on X Data Risks

Privacy advocates warn the FTC that Elon Musk’s X poses a serious risk to Americans’ privacy and data security, urging the agency to reject X’s bid to end ongoing audits.

Civic News India

Read

Jul 02, 2026

OpenAI Offers US Government 5% Stake in Deal

OpenAI CEO Sam Altman is in talks with the Trump administration to give the US a 5% stake in the AI firm, a far smaller share than Senator Bernie Sanders proposed.

Civic News India

Read

Jul 02, 2026

Microsoft Frontier Co: $2.5B AI Deployment Push

Microsoft launches a new AI deployment subsidiary called Microsoft Frontier Co. with a $2.5 billion investment and 6,000 employees to help clients implement AI.

Civic News India

Read

Jul 02, 2026

OpenAI Offers 5% Equity to US Sovereign Wealth Fund

OpenAI CEO Sam Altman has proposed giving 5% of the company’s equity to a U.S. sovereign wealth fund, allowing the public to share in AI gains.

Civic News India

Read

Jul 02, 2026

Claude Science Beta Integrates NVIDIA BioNeMo for Research

Anthropic launches Claude Science public beta with NVIDIA BioNeMo Agent Toolkit integration, giving life sciences researchers GPU-accelerated AI tools for faster discovery workflows.

Civic News India

Read